ARTICLE | Company News
Neurocrine other research news
November 20, 1995 8:00 AM UTC
Neurocrine published animal and post-mortem human findings showing the possible use of ligands to displace CRF from its binding protein as a means of improving memory in Alzheimer's.
Company researchers and collaborators at Johns Hopkins University confirmed that levels of CRF in brain tissue from people who died with the disease are much lower than in people who died without evidence of the disorder. ...